GILD logo

Gilead Sciences (GILD) Operating Profit

Annual Operating Profit

$8.81 B
-$2.16 B-19.72%

31 December 2023

GILD Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Profit

$3.14 B
+$462.00 M+17.23%

30 September 2024

GILD Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Operating Profit

$7.64 B
+$430.00 M+5.96%

30 September 2024

GILD TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GILD Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+56.5%-13.2%
3 y3 years-18.9%+95.3%-29.6%
5 y5 years-5.7%+66.0%-17.1%

GILD Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-19.7%at low-38.7%+1745.5%-41.0%+18.8%
5 y5 years-19.7%at low-38.7%+1745.5%-41.0%+18.8%
alltimeall time-60.3%+7399.8%-44.1%+1745.5%-65.6%+6431.1%

Gilead Sciences Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
$3.14 B(+17.2%)
$7.64 B(+6.0%)
June 2024
-
$2.68 B(-1503.7%)
$7.21 B(+12.1%)
Mar 2024
-
-$191.00 M(-109.5%)
$6.43 B(-27.0%)
Dec 2023
$8.81 B(-19.7%)
$2.01 B(-26.0%)
$8.81 B(-26.1%)
Sept 2023
-
$2.71 B(+42.7%)
$11.92 B(-4.6%)
June 2023
-
$1.90 B(-13.0%)
$12.50 B(-3.5%)
Mar 2023
-
$2.19 B(-57.4%)
$12.95 B(+18.0%)
Dec 2022
$10.97 B(+1.1%)
$5.13 B(+56.0%)
$10.97 B(+47.1%)
Sept 2022
-
$3.29 B(+39.3%)
$7.46 B(-7.7%)
June 2022
-
$2.36 B(+1050.7%)
$8.08 B(-0.3%)
Mar 2022
-
$205.00 M(-87.3%)
$8.11 B(-25.3%)
Dec 2021
$10.86 B(+9.4%)
$1.61 B(-58.8%)
$10.85 B(-9.2%)
Sept 2021
-
$3.91 B(+63.9%)
$11.96 B(+6.5%)
June 2021
-
$2.38 B(-19.2%)
$11.22 B(+8.1%)
Mar 2021
-
$2.95 B(+8.7%)
$10.38 B(+4.6%)
Dec 2020
$9.93 B(+6.3%)
$2.71 B(-14.4%)
$9.93 B(+9.0%)
Sept 2020
-
$3.17 B(+105.8%)
$9.11 B(+8.1%)
June 2020
-
$1.54 B(-38.3%)
$8.42 B(-11.1%)
Mar 2020
-
$2.50 B(+32.0%)
$9.47 B(+2.8%)
Dec 2019
$9.34 B(+0.4%)
$1.89 B(-23.9%)
$9.21 B(-3.7%)
Sept 2019
-
$2.49 B(-4.2%)
$9.56 B(-1.4%)
June 2019
-
$2.60 B(+16.0%)
$9.70 B(+3.4%)
Mar 2019
-
$2.24 B(-0.2%)
$9.38 B(+0.9%)
Dec 2018
$9.30 B(-34.2%)
$2.24 B(-14.5%)
$9.30 B(-0.5%)
Sept 2018
-
$2.62 B(+15.0%)
$9.35 B(-11.3%)
June 2018
-
$2.28 B(+5.9%)
$10.54 B(-15.8%)
Mar 2018
-
$2.15 B(-6.0%)
$12.51 B(-11.4%)
Dec 2017
$14.12 B(-19.9%)
$2.29 B(-39.9%)
$14.12 B(-11.0%)
Sept 2017
-
$3.81 B(-10.4%)
$15.88 B(-3.6%)
June 2017
-
$4.25 B(+12.9%)
$16.46 B(-1.7%)
Mar 2017
-
$3.77 B(-6.9%)
$16.75 B(-5.0%)
Dec 2016
$17.63 B(-20.5%)
$4.04 B(-8.0%)
$17.63 B(-8.2%)
Sept 2016
-
$4.40 B(-3.1%)
$19.21 B(-5.8%)
June 2016
-
$4.54 B(-2.4%)
$20.39 B(-5.0%)
Mar 2016
-
$4.65 B(-17.3%)
$21.47 B(-3.2%)
Dec 2015
$22.19 B(+45.4%)
$5.62 B(+0.6%)
$22.19 B(+6.2%)
Sept 2015
-
$5.58 B(-0.6%)
$20.90 B(+11.2%)
June 2015
-
$5.62 B(+4.6%)
$18.80 B(+6.8%)
Mar 2015
-
$5.37 B(+24.0%)
$17.59 B(+15.3%)
Dec 2014
$15.27 B(+237.4%)
$4.33 B(+24.4%)
$15.27 B(+25.8%)
Sept 2014
-
$3.48 B(-21.1%)
$12.13 B(+23.8%)
June 2014
-
$4.41 B(+45.0%)
$9.80 B(+49.8%)
Mar 2014
-
$3.04 B(+154.2%)
$6.54 B(+44.6%)
Dec 2013
$4.52 B(+12.8%)
$1.20 B(+4.3%)
$4.52 B(+2.0%)
Sept 2013
-
$1.15 B(-0.5%)
$4.43 B(+2.4%)
June 2013
-
$1.15 B(+12.5%)
$4.33 B(+2.2%)
Mar 2013
-
$1.03 B(-7.4%)
$4.24 B(+5.6%)
Dec 2012
$4.01 B(+5.8%)
$1.11 B(+6.0%)
$4.01 B(+6.3%)
Sept 2012
-
$1.04 B(-1.4%)
$3.77 B(+1.1%)
June 2012
-
$1.06 B(+32.4%)
$3.73 B(+1.1%)
Mar 2012
-
$800.19 M(-7.8%)
$3.69 B(-2.7%)
Dec 2011
$3.79 B(-4.4%)
$867.48 M(-13.6%)
$3.79 B(+1.0%)
Sept 2011
-
$1.00 B(-1.3%)
$3.75 B(+0.7%)
June 2011
-
$1.02 B(+12.7%)
$3.73 B(+0.7%)
Mar 2011
-
$901.97 M(+8.8%)
$3.70 B(-6.5%)
Dec 2010
$3.96 B(+12.3%)
$829.38 M(-15.3%)
$3.96 B(-5.6%)
Sept 2010
-
$979.07 M(-1.4%)
$4.20 B(+2.1%)
June 2010
-
$992.63 M(-14.5%)
$4.11 B(+6.0%)
Mar 2010
-
$1.16 B(+9.0%)
$3.88 B(+10.0%)
Dec 2009
$3.53 B(+31.2%)
$1.07 B(+19.1%)
$3.53 B(+11.2%)
Sept 2009
-
$894.41 M(+17.5%)
$3.17 B(+6.7%)
June 2009
-
$761.06 M(-5.8%)
$2.97 B(+5.1%)
Mar 2009
-
$808.32 M(+13.7%)
$2.83 B(+5.2%)
Dec 2008
$2.69 B(+24.2%)
$711.15 M(+2.5%)
$2.69 B(+7.9%)
Sept 2008
-
$693.83 M(+12.6%)
$2.49 B(+6.3%)
June 2008
-
$616.37 M(-7.7%)
$2.35 B(+3.2%)
Mar 2008
-
$668.05 M(+29.8%)
$2.27 B(+5.0%)
Dec 2007
$2.16 B
$514.49 M(-5.9%)
$2.16 B(+1.4%)
Sept 2007
-
$547.03 M(+0.8%)
$2.14 B(+6.7%)
DateAnnualQuarterlyTTM
June 2007
-
$542.85 M(-3.1%)
$2.00 B(+9.7%)
Mar 2007
-
$560.14 M(+15.4%)
$1.82 B(+11.5%)
Dec 2006
$1.64 B(+47.4%)
$485.22 M(+17.5%)
$1.64 B(+8.3%)
Sept 2006
-
$413.11 M(+13.1%)
$1.51 B(+12.3%)
June 2006
-
$365.31 M(-1.7%)
$1.35 B(+7.0%)
Mar 2006
-
$371.65 M(+3.3%)
$1.26 B(+13.4%)
Dec 2005
$1.11 B(+76.8%)
$359.84 M(+45.0%)
$1.11 B(+21.8%)
Sept 2005
-
$248.25 M(-10.5%)
$910.22 M(+10.2%)
June 2005
-
$277.50 M(+24.2%)
$825.74 M(+16.9%)
Mar 2005
-
$223.48 M(+38.8%)
$706.44 M(+12.6%)
Dec 2004
$627.39 M(+90.2%)
$161.00 M(-1.7%)
$627.39 M(+13.2%)
Sept 2004
-
$163.77 M(+3.5%)
$554.37 M(+18.0%)
June 2004
-
$158.20 M(+9.5%)
$469.77 M(+12.0%)
Mar 2004
-
$144.42 M(+64.2%)
$419.35 M(+27.1%)
Dec 2003
$329.92 M(+307.3%)
$87.98 M(+11.1%)
$329.92 M(+20.1%)
Sept 2003
-
$79.17 M(-26.5%)
$274.79 M(+18.7%)
June 2003
-
$107.77 M(+95.9%)
$231.53 M(+62.0%)
Mar 2003
-
$55.00 M(+67.5%)
$142.95 M(+76.5%)
Dec 2002
$81.01 M(-167.1%)
$32.84 M(-8.6%)
$81.01 M(+248.5%)
Sept 2002
-
$35.92 M(+87.1%)
$23.24 M(-147.7%)
June 2002
-
$19.19 M(-376.5%)
-$48.74 M(-52.1%)
Mar 2002
-
-$6.94 M(-72.1%)
-$101.83 M(-15.6%)
Dec 2001
-$120.69 M(+130.7%)
-$24.92 M(-30.9%)
-$120.69 M(+5.5%)
Sept 2001
-
-$36.07 M(+6.4%)
-$114.42 M(+15.2%)
June 2001
-
-$33.90 M(+31.4%)
-$99.29 M(+39.8%)
Mar 2001
-
-$25.80 M(+38.3%)
-$71.03 M(+43.0%)
Dec 2000
-$52.32 M(+1.2%)
-$18.65 M(-10.9%)
-$49.68 M(+119.5%)
Sept 2000
-
-$20.94 M(+271.6%)
-$22.63 M(-31.2%)
June 2000
-
-$5.63 M(+26.6%)
-$32.89 M(-17.0%)
Mar 2000
-
-$4.45 M(-153.0%)
-$39.62 M(-23.4%)
Dec 1999
-$51.70 M(-34.0%)
$8.40 M(-126.9%)
-$51.72 M(-36.2%)
Sept 1999
-
-$31.20 M(+152.4%)
-$81.02 M(+13.4%)
June 1999
-
-$12.36 M(-25.3%)
-$71.42 M(-9.4%)
Mar 1999
-
-$16.55 M(-20.8%)
-$78.85 M(+5.8%)
Dec 1998
-$78.30 M(+8.6%)
-$20.90 M(-3.2%)
-$74.50 M(-23.4%)
Sept 1998
-
-$21.60 M(+9.1%)
-$97.20 M(+7.2%)
June 1998
-
-$19.80 M(+62.3%)
-$90.70 M(+25.4%)
Mar 1998
-
-$12.20 M(-72.0%)
-$72.30 M(+0.4%)
Dec 1997
-$72.10 M(+99.7%)
-$43.60 M(+188.7%)
-$72.00 M(+76.9%)
Sept 1997
-
-$15.10 M(+978.6%)
-$40.70 M(+102.5%)
June 1997
-
-$1.40 M(-88.2%)
-$20.10 M(-41.9%)
Mar 1997
-
-$11.90 M(-3.3%)
-$34.60 M(-3.9%)
Dec 1996
-$36.10 M(+12.8%)
-$12.30 M(-323.6%)
-$36.00 M(+51.9%)
Sept 1996
-
$5.50 M(-134.6%)
-$23.70 M(-39.4%)
June 1996
-
-$15.90 M(+19.5%)
-$39.10 M(+21.4%)
Mar 1996
-
-$13.30 M(+34.3%)
-$32.20 M(-15.5%)
Dec 1995
-$32.00 M(-9.1%)
-
-
Sept 1995
-
-$9.90 M(+10.0%)
-$38.10 M(+5.5%)
June 1995
-
-$9.00 M(-10.0%)
-$36.10 M(+2.6%)
Mar 1995
-
-$10.00 M(+8.7%)
-$35.20 M(+2.6%)
Mar 1995
-$35.20 M(+19.3%)
-
-
Dec 1994
-
-$9.20 M(+16.5%)
-$34.30 M(+4.9%)
Sept 1994
-
-$7.90 M(-2.5%)
-$32.70 M(+3.5%)
June 1994
-
-$8.10 M(-11.0%)
-$31.60 M(+7.8%)
Mar 1994
-$29.50 M(+62.1%)
-$9.10 M(+19.7%)
-$29.30 M(+8.1%)
Dec 1993
-
-$7.60 M(+11.8%)
-$27.10 M(+11.5%)
Sept 1993
-
-$6.80 M(+17.2%)
-$24.30 M(+14.6%)
June 1993
-
-$5.80 M(-15.9%)
-$21.20 M(+16.5%)
Mar 1993
-$18.20 M(+188.9%)
-$6.90 M(+43.8%)
-$18.20 M(-1.6%)
Dec 1992
-
-$4.80 M(+29.7%)
-$18.50 M(+40.2%)
Sept 1992
-
-$3.70 M(+32.1%)
-$13.20 M(+41.9%)
June 1992
-
-$2.80 M(-61.1%)
-$9.30 M(+47.6%)
Mar 1992
-$6.30 M(+31.3%)
-$7.20 M(-1540.0%)
-$6.30 M(+57.5%)
Dec 1991
-
$500.00 K(+150.0%)
-$4.00 M(-9.1%)
Sept 1991
-
$200.00 K(0.0%)
-$4.40 M(-2.2%)
June 1991
-
$200.00 K(-104.1%)
-$4.50 M(-2.2%)
Mar 1991
-$4.80 M
-$4.90 M(-5000.0%)
-$4.60 M(-1633.3%)
Dec 1990
-
$100.00 K(0.0%)
$300.00 K(+50.0%)
Sept 1990
-
$100.00 K(0.0%)
$200.00 K(+100.0%)
June 1990
-
$100.00 K
$100.00 K

FAQ

  • What is Gilead Sciences annual operaing income?
  • What is the all time high annual operating profit for Gilead Sciences?
  • What is Gilead Sciences quarterly operating income?
  • What is the all time high quarterly operating profit for Gilead Sciences?
  • What is Gilead Sciences quarterly operating profit year-on-year change?
  • What is Gilead Sciences TTM operating income?
  • What is the all time high TTM operating profit for Gilead Sciences?
  • What is Gilead Sciences TTM operating profit year-on-year change?

What is Gilead Sciences annual operaing income?

The current annual operating profit of GILD is $8.81 B

What is the all time high annual operating profit for Gilead Sciences?

Gilead Sciences all-time high annual operaing income is $22.19 B

What is Gilead Sciences quarterly operating income?

The current quarterly operating profit of GILD is $3.14 B

What is the all time high quarterly operating profit for Gilead Sciences?

Gilead Sciences all-time high quarterly operating income is $5.62 B

What is Gilead Sciences quarterly operating profit year-on-year change?

Over the past year, GILD quarterly operating income has changed by +$1.14 B (+56.52%)

What is Gilead Sciences TTM operating income?

The current TTM operating profit of GILD is $7.64 B

What is the all time high TTM operating profit for Gilead Sciences?

Gilead Sciences all-time high TTM operating income is $22.19 B

What is Gilead Sciences TTM operating profit year-on-year change?

Over the past year, GILD TTM operating income has changed by -$1.17 B (-13.24%)